December 12, 2008 - Cardiac Advancements LLC, a provider of remote cardiac monitoring services and products, and Cardiostaff Corp. have partnered to provide enhance cardiac care across the nation.
Cardiostaff provides physician practices and hospitals with 24/7 patient arrhythmia information for patient diagnosis and arrhythmia therapy management. Services include: 30-Day event monitoring, digital holter monitoring, atrial fibrillation monitoring, pacemaker follow-up and remote telemetry monitoring.
Cardiac Advancements plans to expand the Cardiostaff services to its Milwaukee location and increase its outreach throughout the country.
With over 30 years of experience in both service and manufacturing, the Cardiac Advancements has contributed several medical devices to the industry, including the new Lechnologies AfibAlert. Developed to detect the life threatening yet often undetected heart irregularity known as atrial fibrillation (AF), AfibAlert is the first monitor that allows patients to take daily readings of their heart rhythm at home. Clinical studies have demonstrated that if detected within 48 hours of onset, AF can be controlled or terminated before a catastrophic event occurs.
Together, this partnership provides the cardiac care community with a valuable combination of service, research and technology, offering a variety of cardiac monitoring & diagnostic devices — as well as cardiac monitoring services provided to patients, physicians and hospitals throughout the country.
For more information: www.lechnologies.com, www.cardiostaff.com